Zobrazeno 1 - 10
of 237
pro vyhledávání: '"W Virgil, Brown"'
Autor:
Nuntakorn Thongtang, Margaret R. Diffenderfer, Esther M.M. Ooi, P. Hugh R. Barrett, Scott M. Turner, Ngoc-Anh Le, W. Virgil Brown, Ernst J. Schaefer
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 7, Pp 1315-1324 (2017)
Small dense LDL (sdLDL) has been reported to be more atherogenic than large buoyant LDL (lbLDL). We examined the metabolism and protein composition of sdLDL and lbLDL in six subjects with combined hyperlipidemia on placebo and rosuvastatin 40 mg/day.
Externí odkaz:
https://doaj.org/article/bbaf1b6f3bb64fa0936b86dcc2d2e91c
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 10, Pp 1875-1882 (1999)
ApoC-III and apoE are important determinants of intravascular lipolysis and clearance of triglyceride-rich chylomicrons and VLDL from the blood plasma. Interactions of these two apolipoproteins were studied by adding purified human apoC-III to human
Externí odkaz:
https://doaj.org/article/7c945827dae74d17b516088d972c6b9b
Publikováno v:
Journal of Lipid Research, Vol 39, Iss 3, Pp 679-690 (1998)
We have validated a semi-automatic procedure for the efficient isolation of plasma lipoproteins from 300 μl of whole plasma (actual injection volume 200 μl) by Fast Phase Liquid Chromatography (FPLC). Modified enzymatic assays were established to a
Externí odkaz:
https://doaj.org/article/13629bb1cec6433dad1327fc1bfc1da5
Autor:
Alberico L. Catapano, Andrew M. Tershakovec, Harold E. Bays, Peter P. Toth, W. Virgil Brown, Joanne E. Tomassini, Michel Farnier, Erin Jensen, Michael H. Davidson, Adam B. Polis
Publikováno v:
Journal of clinical lipidology. 13(6)
Elevated remnant lipoprotein cholesterol (RLP-C) levels increase cardiovascular disease risk. However, RLP-C measurement methods are not standardized, leading to variations across studies.To evaluate the effect of ezetimibe (Eze) + statins vs statin
Autor:
JoAnne M. Foody, W. Virgil Brown, Franklin J. Zieve, Andrew M. Tershakovec, Arvind Shah, Joanne E. Tomassini
Publikováno v:
Journal of Clinical Lipidology. 10:116-123
Background Little is known regarding relationships between high-sensitivity C-reactive protein (hsCRP) and lipoproteins other than low-density lipoprotein cholesterol (LDL-C). High-density lipoprotein (HDL), with both anti-inflammatory and cholestero
Publikováno v:
Journal of Clinical Lipidology. 10:5-14
The roundtable this month will involve a discussion of two new drugs that have been approved by the Food and Drug Administration for the reduction of low-density lipoprotein cholesterol (LDL-C). The Food and Drug Administration approved the first of
Autor:
W. Virgil Brown
Publikováno v:
Journal of Clinical Lipidology. 9:727-730
Publikováno v:
Journal of Clinical Lipidology. 9:634-639
Publikováno v:
Journal of Clinical Lipidology. 9:486-495
The first efforts to uncover the causes of cardiovascular disease focused on the behavioral, now called lifestyle habits of populations. Diet, exercise, and smoking were recognized as important issues with strong relationships in community-based obse
Autor:
W. Virgil Brown
Publikováno v:
Journal of Clinical Lipidology. 9:479-483